| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| DVA - DaVita HealthCare Partners Inc | SELL | -100 @ USD 140.83 | USD -14,083 | The ETF sold 100 shares of DVA on 2026-02-06. The shares were previously bought for an average price of USD 138.07. The DaVita HealthCare Partners Inc shares were sold for 2.0% higher than average price of previous purchases. This sale made a profit of USD 276 The average price that the ETF previously sold DVA share for is USD 140.614 so the ETF has sold 100 shares on 2026-02-06 at a higher price than the previous selling average. |
| MOH - MOH | SELL | -112 @ USD 131.72 | USD -14,753 | The ETF sold 112 shares of MOH on 2026-02-06. The shares were previously bought for an average price of USD 237.36. The MOH shares were sold for -44.5% lower than average price of previous purchases. This resulted in an overall loss of USD 11,832 The average price that the ETF previously sold MOH share for is USD 259.452 which is higher than the selling price of USD 131.72 on 2026-02-06. |
| MOH - LVMH Moët Hennessy - Louis Vuitton Société Européenne | SELL | -112 @ USD 131.72 | USD -14,753 | The ETF sold 112 shares of MOH on 2026-02-06. The shares were previously bought for an average price of USD 237.36. The LVMH Moët Hennessy - Louis Vuitton Société Européenne shares were sold for -44.5% lower than average price of previous purchases. This resulted in an overall loss of USD 11,832 The average price that the ETF previously sold MOH share for is USD 259.452 which is higher than the selling price of USD 131.72 on 2026-02-06. |
| HSIC - Henry Schein Inc | SELL | -290 @ USD 79.72 | USD -23,119 | The ETF sold 290 shares of HSIC on 2026-02-06. The shares were previously bought for an average price of USD 72.3397. The Henry Schein Inc shares were sold for 10.2% higher than average price of previous purchases. This sale made a profit of USD 2,140 The average price that the ETF previously sold HSIC share for is USD 70.169 so the ETF has sold 290 shares on 2026-02-06 at a higher price than the previous selling average. |
| CRL - Creightons Plc | SELL | -135 @ USD 189.21 | USD -25,543 | The ETF sold 135 shares of CRL on 2026-02-06. The shares were previously bought for an average price of USD 174.616. The Creightons Plc shares were sold for 8.4% higher than average price of previous purchases. This sale made a profit of USD 1,970 The average price that the ETF previously sold CRL share for is USD 176.484 so the ETF has sold 135 shares on 2026-02-06 at a higher price than the previous selling average. |
| TECH - Bio-Techne Corp | SELL | -435 @ USD 66.78 | USD -29,049 | The ETF sold 435 shares of TECH on 2026-02-06. The shares were previously bought for an average price of USD 62.2885. The Bio-Techne Corp shares were sold for 7.2% higher than average price of previous purchases. This sale made a profit of USD 1,954 The average price that the ETF previously sold TECH share for is USD 64.988 so the ETF has sold 435 shares on 2026-02-06 at a higher price than the previous selling average. |
| BAX - Baxter International Inc | SELL | -1,435 @ USD 21.73 | USD -31,183 | The ETF sold 1435 shares of BAX on 2026-02-06. The shares were previously bought for an average price of USD 26.6705. The Baxter International Inc shares were sold for -18.5% lower than average price of previous purchases. This resulted in an overall loss of USD 7,090 The average price that the ETF previously sold BAX share for is USD 29.5915 which is higher than the selling price of USD 21.73 on 2026-02-06. |
| SOLV - Solventum Corp. | SELL | -405 @ USD 78.12 | USD -31,639 | The ETF sold 405 shares of SOLV on 2026-02-06. The shares were previously bought for an average price of USD 75.4532. The Solventum Corp. shares were sold for 3.5% higher than average price of previous purchases. This sale made a profit of USD 1,080 The average price that the ETF previously sold SOLV share for is USD 73.6355 so the ETF has sold 405 shares on 2026-02-06 at a higher price than the previous selling average. |
| RVTY - Revvity Inc. | SELL | -315 @ USD 101.59 | USD -32,001 | The ETF sold 315 shares of RVTY on 2026-02-06. The shares were previously bought for an average price of USD 104.892. The Revvity Inc. shares were sold for -3.1% lower than average price of previous purchases. This resulted in an overall loss of USD 1,040 The average price that the ETF previously sold RVTY share for is USD 105.475 which is higher than the selling price of USD 101.59 on 2026-02-06. |
| UHS - Universal Health Services Inc | SELL | -150 @ USD 218.56 | USD -32,784 | The ETF sold 150 shares of UHS on 2026-02-06. The shares were previously bought for an average price of USD 201.2. The Universal Health Services Inc shares were sold for 8.6% higher than average price of previous purchases. This sale made a profit of USD 2,604 The average price that the ETF previously sold UHS share for is USD 200.759 so the ETF has sold 150 shares on 2026-02-06 at a higher price than the previous selling average. |
| ALGN - Align Technology Inc | SELL | -185 @ USD 187.6 | USD -34,706 | The ETF sold 185 shares of ALGN on 2026-02-06. The shares were previously bought for an average price of USD 170.008. The Align Technology Inc shares were sold for 10.3% higher than average price of previous purchases. This sale made a profit of USD 3,255 The average price that the ETF previously sold ALGN share for is USD 195.021 which is higher than the selling price of USD 187.6 on 2026-02-06. |
| MRNA - Moderna Inc | SELL | -960 @ USD 41.01 | USD -39,370 | The ETF sold 960 shares of MRNA on 2026-02-06. The shares were previously bought for an average price of USD 31.9516. The Moderna Inc shares were sold for 28.4% higher than average price of previous purchases. This sale made a profit of USD 8,696 The average price that the ETF previously sold MRNA share for is USD 36.5125 so the ETF has sold 960 shares on 2026-02-06 at a higher price than the previous selling average. |
| COO - The Cooper Companies, Inc. Common Stock | SELL | -559 @ USD 82.1 | USD -45,894 | The ETF sold 559 shares of COO on 2026-02-06. The shares were previously bought for an average price of USD 81.8085. The The Cooper Companies, Inc. Common Stock shares were sold for 0.4% higher than average price of previous purchases. This sale made a profit of USD 163 The average price that the ETF previously sold COO share for is USD 87.7003 which is higher than the selling price of USD 82.1 on 2026-02-06. |
| PODD - Insulet Corporation | SELL | -190 @ USD 241.93 | USD -45,967 | The ETF sold 190 shares of PODD on 2026-02-06. The shares were previously bought for an average price of USD 290.833. The Insulet Corporation shares were sold for -16.8% lower than average price of previous purchases. This resulted in an overall loss of USD 9,292 The average price that the ETF previously sold PODD share for is USD 280.375 which is higher than the selling price of USD 241.93 on 2026-02-06. |
| HOLX - Hologic Inc | SELL | -620 @ USD 74.81 | USD -46,382 | The ETF sold 620 shares of HOLX on 2026-02-06. The shares were previously bought for an average price of USD 69.5768. The Hologic Inc shares were sold for 7.5% higher than average price of previous purchases. This sale made a profit of USD 3,245 The average price that the ETF previously sold HOLX share for is USD 71.1637 so the ETF has sold 620 shares on 2026-02-06 at a higher price than the previous selling average. |
| VTRS - Viatris Inc | SELL | -3,225 @ USD 14.58 | USD -47,021 | The ETF sold 3225 shares of VTRS on 2026-02-06. The shares were previously bought for an average price of USD 10.6209. The Viatris Inc shares were sold for 37.3% higher than average price of previous purchases. This sale made a profit of USD 12,768 The average price that the ETF previously sold VTRS share for is USD 11.072 so the ETF has sold 3225 shares on 2026-02-06 at a higher price than the previous selling average. |
| WST - West Pharmaceutical Services Inc | SELL | -200 @ USD 248.95 | USD -49,790 | The ETF sold 200 shares of WST on 2026-02-06. The shares were previously bought for an average price of USD 262.863. The West Pharmaceutical Services Inc shares were sold for -5.3% lower than average price of previous purchases. This resulted in an overall loss of USD 2,783 The average price that the ETF previously sold WST share for is USD 276.951 which is higher than the selling price of USD 248.95 on 2026-02-06. |
| INCY - Incyte Corporation | SELL | -460 @ USD 108.39 | USD -49,859 | The ETF sold 460 shares of INCY on 2026-02-06. The shares were previously bought for an average price of USD 82.4011. The Incyte Corporation shares were sold for 31.5% higher than average price of previous purchases. This sale made a profit of USD 11,955 The average price that the ETF previously sold INCY share for is USD 78.4856 so the ETF has sold 460 shares on 2026-02-06 at a higher price than the previous selling average. |
| ZBH - Zimmer Biomet Holdings Inc | SELL | -555 @ USD 89.91 | USD -49,900 | The ETF sold 555 shares of ZBH on 2026-02-06. The shares were previously bought for an average price of USD 99.6479. The Zimmer Biomet Holdings Inc shares were sold for -9.8% lower than average price of previous purchases. This resulted in an overall loss of USD 5,405 The average price that the ETF previously sold ZBH share for is USD 102.134 which is higher than the selling price of USD 89.91 on 2026-02-06. |
| CNC - Concurrent Technologies Plc | SELL | -1,305 @ USD 38.46 | USD -50,190 | The ETF sold 1305 shares of CNC on 2026-02-06. The shares were previously bought for an average price of USD 49.0109. The Concurrent Technologies Plc shares were sold for -21.5% lower than average price of previous purchases. This resulted in an overall loss of USD 13,769 The average price that the ETF previously sold CNC share for is USD 50.0571 which is higher than the selling price of USD 38.46 on 2026-02-06. |
| DGX - Quest Diagnostics Incorporated | SELL | -315 @ USD 190.71 | USD -60,074 | The ETF sold 315 shares of DGX on 2026-02-06. The shares were previously bought for an average price of USD 175.553. The Quest Diagnostics Incorporated shares were sold for 8.6% higher than average price of previous purchases. This sale made a profit of USD 4,774 The average price that the ETF previously sold DGX share for is USD 169.268 so the ETF has sold 315 shares on 2026-02-06 at a higher price than the previous selling average. |
| WAT - Waters Corporation | SELL | -165 @ USD 381.29 | USD -62,913 | The ETF sold 165 shares of WAT on 2026-02-06. The shares were previously bought for an average price of USD 365.28. The Waters Corporation shares were sold for 4.4% higher than average price of previous purchases. This sale made a profit of USD 2,642 The average price that the ETF previously sold WAT share for is USD 366.666 so the ETF has sold 165 shares on 2026-02-06 at a higher price than the previous selling average. |
| WAT - MULETFWATIMETFP | SELL | -165 @ USD 381.29 | USD -62,913 | The ETF sold 165 shares of WAT on 2026-02-06. The shares were previously bought for an average price of USD 365.28. The MULETFWATIMETFP shares were sold for 4.4% higher than average price of previous purchases. This sale made a profit of USD 2,642 The average price that the ETF previously sold WAT share for is USD 366.666 so the ETF has sold 165 shares on 2026-02-06 at a higher price than the previous selling average. |
| LH - Laboratory Corporation of America Holdings | SELL | -230 @ USD 277.2 | USD -63,756 | The ETF sold 230 shares of LH on 2026-02-06. The shares were previously bought for an average price of USD 256.286. The Laboratory Corporation of America Holdings shares were sold for 8.2% higher than average price of previous purchases. This sale made a profit of USD 4,810 The average price that the ETF previously sold LH share for is USD 247.336 so the ETF has sold 230 shares on 2026-02-06 at a higher price than the previous selling average. |
| HUM - Hummingbird Resources PLC | SELL | -335 @ USD 193.94 | USD -64,970 | The ETF sold 335 shares of HUM on 2026-02-06. The shares were previously bought for an average price of USD 263.212. The Hummingbird Resources PLC shares were sold for -26.3% lower than average price of previous purchases. This resulted in an overall loss of USD 23,206 The average price that the ETF previously sold HUM share for is USD 267.635 which is higher than the selling price of USD 193.94 on 2026-02-06. |
| HUM - Humana Inc | SELL | -335 @ USD 193.94 | USD -64,970 | The ETF sold 335 shares of HUM on 2026-02-06. The shares were previously bought for an average price of USD 263.212. The Humana Inc shares were sold for -26.3% lower than average price of previous purchases. This resulted in an overall loss of USD 23,206 The average price that the ETF previously sold HUM share for is USD 267.635 which is higher than the selling price of USD 193.94 on 2026-02-06. |
| STE - STERIS plc | SELL | -275 @ USD 252.16 | USD -69,344 | The ETF sold 275 shares of STE on 2026-02-06. The shares were previously bought for an average price of USD 239.073. The STERIS plc shares were sold for 5.5% higher than average price of previous purchases. This sale made a profit of USD 3,599 The average price that the ETF previously sold STE share for is USD 230.512 so the ETF has sold 275 shares on 2026-02-06 at a higher price than the previous selling average. |
| MTD - Mettler-Toledo International Inc | SELL | -55 @ USD 1373.57 | USD -75,546 | The ETF sold 55 shares of MTD on 2026-02-06. The shares were previously bought for an average price of USD 1316.06. The Mettler-Toledo International Inc shares were sold for 4.4% higher than average price of previous purchases. This sale made a profit of USD 3,163 The average price that the ETF previously sold MTD share for is USD 1270.96 so the ETF has sold 55 shares on 2026-02-06 at a higher price than the previous selling average. |
| MTD - AMUNDI EUR GOV 710 | SELL | -55 @ USD 1373.57 | USD -75,546 | The ETF sold 55 shares of MTD on 2026-02-06. The shares were previously bought for an average price of USD 1316.06. The AMUNDI EUR GOV 710 shares were sold for 4.4% higher than average price of previous purchases. This sale made a profit of USD 3,163 The average price that the ETF previously sold MTD share for is USD 1270.96 so the ETF has sold 55 shares on 2026-02-06 at a higher price than the previous selling average. |
| DXCM - DexCom Inc | SELL | -1,091 @ USD 69.97 | USD -76,337 | The ETF sold 1091 shares of DXCM on 2026-02-06. The shares were previously bought for an average price of USD 72.3304. The DexCom Inc shares were sold for -3.3% lower than average price of previous purchases. This resulted in an overall loss of USD 2,575 The average price that the ETF previously sold DXCM share for is USD 75.1216 which is higher than the selling price of USD 69.97 on 2026-02-06. |
| BIIB - Biogen Inc | SELL | -405 @ USD 201.18 | USD -81,478 | The ETF sold 405 shares of BIIB on 2026-02-06. The shares were previously bought for an average price of USD 152.133. The Biogen Inc shares were sold for 32.2% higher than average price of previous purchases. This sale made a profit of USD 19,864 The average price that the ETF previously sold BIIB share for is USD 155.094 so the ETF has sold 405 shares on 2026-02-06 at a higher price than the previous selling average. |
| IQV - IQVIA Holdings Inc | SELL | -475 @ USD 187.49 | USD -89,058 | The ETF sold 475 shares of IQV on 2026-02-06. The shares were previously bought for an average price of USD 201.348. The IQVIA Holdings Inc shares were sold for -6.9% lower than average price of previous purchases. This resulted in an overall loss of USD 6,583 The average price that the ETF previously sold IQV share for is USD 194.212 which is higher than the selling price of USD 187.49 on 2026-02-06. |
| A - Agilent Technologies Inc | SELL | -785 @ USD 129.58 | USD -101,720 | The ETF sold 785 shares of A on 2026-02-06. The shares were previously bought for an average price of USD 134.48. The Agilent Technologies Inc shares were sold for -3.6% lower than average price of previous purchases. This resulted in an overall loss of USD 3,846 The average price that the ETF previously sold A share for is USD 132.068 which is higher than the selling price of USD 129.58 on 2026-02-06. |
| GEHC - GE HealthCare Technologies Inc. | SELL | -1,265 @ USD 80.65 | USD -102,022 | The ETF sold 1265 shares of GEHC on 2026-02-06. The shares were previously bought for an average price of USD 80.5862. The GE HealthCare Technologies Inc. shares were sold for 0.1% higher than average price of previous purchases. This sale made a profit of USD 81 The average price that the ETF previously sold GEHC share for is USD 79.5617 so the ETF has sold 1265 shares on 2026-02-06 at a higher price than the previous selling average. |
| RMD - ResMed Inc | SELL | -405 @ USD 271.63 | USD -110,010 | The ETF sold 405 shares of RMD on 2026-02-06. The shares were previously bought for an average price of USD 247.901. The ResMed Inc shares were sold for 9.6% higher than average price of previous purchases. This sale made a profit of USD 9,610 The average price that the ETF previously sold RMD share for is USD 248.038 so the ETF has sold 405 shares on 2026-02-06 at a higher price than the previous selling average. |
| EW - Edwards Lifesciences Corp | SELL | -1,610 @ USD 78.71 | USD -126,723 | The ETF sold 1610 shares of EW on 2026-02-06. The shares were previously bought for an average price of USD 76.2368. The Edwards Lifesciences Corp shares were sold for 3.2% higher than average price of previous purchases. This sale made a profit of USD 3,982 The average price that the ETF previously sold EW share for is USD 74.0666 so the ETF has sold 1610 shares on 2026-02-06 at a higher price than the previous selling average. |
| IDXX - IDEXX Laboratories Inc | SELL | -220 @ USD 644.61 | USD -141,814 | The ETF sold 220 shares of IDXX on 2026-02-06. The shares were previously bought for an average price of USD 573.477. The IDEXX Laboratories Inc shares were sold for 12.4% higher than average price of previous purchases. This sale made a profit of USD 15,649 The average price that the ETF previously sold IDXX share for is USD 510.965 so the ETF has sold 220 shares on 2026-02-06 at a higher price than the previous selling average. |
| CAH - Cardinal Health Inc | SELL | -655 @ USD 226.32 | USD -148,240 | The ETF sold 655 shares of CAH on 2026-02-06. The shares were previously bought for an average price of USD 160.056. The Cardinal Health Inc shares were sold for 41.4% higher than average price of previous purchases. This sale made a profit of USD 43,403 The average price that the ETF previously sold CAH share for is USD 147.56 so the ETF has sold 655 shares on 2026-02-06 at a higher price than the previous selling average. |
| ZTS - Zoetis Inc | SELL | -1,226 @ USD 127.42 | USD -156,217 | The ETF sold 1226 shares of ZTS on 2026-02-06. The shares were previously bought for an average price of USD 147.983. The Zoetis Inc shares were sold for -13.9% lower than average price of previous purchases. This resulted in an overall loss of USD 25,210 The average price that the ETF previously sold ZTS share for is USD 160.794 which is higher than the selling price of USD 127.42 on 2026-02-06. |
| BDX - Becton Dickinson and Company | SELL | -795 @ USD 210.02 | USD -166,966 | The ETF sold 795 shares of BDX on 2026-02-06. The shares were previously bought for an average price of USD 206.122. The Becton Dickinson and Company shares were sold for 1.9% higher than average price of previous purchases. This sale made a profit of USD 3,099 The average price that the ETF previously sold BDX share for is USD 206.007 so the ETF has sold 795 shares on 2026-02-06 at a higher price than the previous selling average. |
| COR - Cencora Inc. | SELL | -535 @ USD 359.25 | USD -192,199 | The ETF sold 535 shares of COR on 2026-02-06. The shares were previously bought for an average price of USD 306.567. The Cencora Inc. shares were sold for 17.2% higher than average price of previous purchases. This sale made a profit of USD 28,185 The average price that the ETF previously sold COR share for is USD 281.613 so the ETF has sold 535 shares on 2026-02-06 at a higher price than the previous selling average. |
| ELV - Elevance Health Inc | SELL | -615 @ USD 338.98 | USD -208,473 | The ETF sold 615 shares of ELV on 2026-02-06. The shares were previously bought for an average price of USD 372.351. The Elevance Health Inc shares were sold for -9.0% lower than average price of previous purchases. This resulted in an overall loss of USD 20,523 The average price that the ETF previously sold ELV share for is USD 384.932 which is higher than the selling price of USD 338.98 on 2026-02-06. |
| ELV - Elevance Health Inc | SELL | -615 @ USD 338.98 | USD -208,473 | The ETF sold 615 shares of ELV on 2026-02-06. The shares were previously bought for an average price of USD 372.351. The Elevance Health Inc shares were sold for -9.0% lower than average price of previous purchases. This resulted in an overall loss of USD 20,523 The average price that the ETF previously sold ELV share for is USD 384.932 which is higher than the selling price of USD 338.98 on 2026-02-06. |
| CI - Cigna Corp | SELL | -740 @ USD 292.05 | USD -216,117 | The ETF sold 740 shares of CI on 2026-02-06. The shares were previously bought for an average price of USD 295.687. The Cigna Corp shares were sold for -1.2% lower than average price of previous purchases. This resulted in an overall loss of USD 2,691 The average price that the ETF previously sold CI share for is USD 310.329 which is higher than the selling price of USD 292.05 on 2026-02-06. |
| REGN - Regeneron Pharmaceuticals Inc | SELL | -280 @ USD 785.51 | USD -219,943 | The ETF sold 280 shares of REGN on 2026-02-06. The shares were previously bought for an average price of USD 681.294. The Regeneron Pharmaceuticals Inc shares were sold for 15.3% higher than average price of previous purchases. This sale made a profit of USD 29,180 The average price that the ETF previously sold REGN share for is USD 691.761 so the ETF has sold 280 shares on 2026-02-06 at a higher price than the previous selling average. |
| HCA - HCA Holdings Inc | SELL | -440 @ USD 501.69 | USD -220,744 | The ETF sold 440 shares of HCA on 2026-02-06. The shares were previously bought for an average price of USD 400.779. The HCA Holdings Inc shares were sold for 25.2% higher than average price of previous purchases. This sale made a profit of USD 44,401 The average price that the ETF previously sold HCA share for is USD 383.229 so the ETF has sold 440 shares on 2026-02-06 at a higher price than the previous selling average. |
| CVS - CVS Health Corp | SELL | -3,515 @ USD 78.35 | USD -275,400 | The ETF sold 3515 shares of CVS on 2026-02-06. The shares were previously bought for an average price of USD 71.0698. The CVS Health Corp shares were sold for 10.2% higher than average price of previous purchases. This sale made a profit of USD 25,590 The average price that the ETF previously sold CVS share for is USD 64.1329 so the ETF has sold 3515 shares on 2026-02-06 at a higher price than the previous selling average. |
| BSX - Boston Scientific Corporation | SELL | -4,099 @ USD 76.27 | USD -312,631 | The ETF sold 4099 shares of BSX on 2026-02-06. The shares were previously bought for an average price of USD 98.1033. The Boston Scientific Corporation shares were sold for -22.3% lower than average price of previous purchases. This resulted in an overall loss of USD 89,495 The average price that the ETF previously sold BSX share for is USD 94.9372 which is higher than the selling price of USD 76.27 on 2026-02-06. |
| BSX - MULSTRXSSXIMETFP | SELL | -4,099 @ USD 76.27 | USD -312,631 | The ETF sold 4099 shares of BSX on 2026-02-06. The shares were previously bought for an average price of USD 98.1033. The MULSTRXSSXIMETFP shares were sold for -22.3% lower than average price of previous purchases. This resulted in an overall loss of USD 89,495 The average price that the ETF previously sold BSX share for is USD 94.9372 which is higher than the selling price of USD 76.27 on 2026-02-06. |
| MCK - McKesson Corporation | SELL | -340 @ USD 948.68 | USD -322,551 | The ETF sold 340 shares of MCK on 2026-02-06. The shares were previously bought for an average price of USD 726.991. The McKesson Corporation shares were sold for 30.5% higher than average price of previous purchases. This sale made a profit of USD 75,374 The average price that the ETF previously sold MCK share for is USD 683.416 so the ETF has sold 340 shares on 2026-02-06 at a higher price than the previous selling average. |
| VRTX - Vertex Pharmaceuticals Inc | SELL | -700 @ USD 477.92 | USD -334,544 | The ETF sold 700 shares of VRTX on 2026-02-06. The shares were previously bought for an average price of USD 448.771. The Vertex Pharmaceuticals Inc shares were sold for 6.5% higher than average price of previous purchases. This sale made a profit of USD 20,404 The average price that the ETF previously sold VRTX share for is USD 465.251 so the ETF has sold 700 shares on 2026-02-06 at a higher price than the previous selling average. |
| SYK - Stryker Corporation | SELL | -950 @ USD 358.29 | USD -340,376 | The ETF sold 950 shares of SYK on 2026-02-06. The shares were previously bought for an average price of USD 371.443. The Stryker Corporation shares were sold for -3.5% lower than average price of previous purchases. This resulted in an overall loss of USD 12,495 The average price that the ETF previously sold SYK share for is USD 377.603 which is higher than the selling price of USD 358.29 on 2026-02-06. |
| BMY - Bloomsbury Publishing Plc | SELL | -5,635 @ USD 61.99 | USD -349,314 | The ETF sold 5635 shares of BMY on 2026-02-06. The shares were previously bought for an average price of USD 52.5852. The Bloomsbury Publishing Plc shares were sold for 17.9% higher than average price of previous purchases. This sale made a profit of USD 52,996 The average price that the ETF previously sold BMY share for is USD 53.0979 so the ETF has sold 5635 shares on 2026-02-06 at a higher price than the previous selling average. |
| MDT - Medtronic PLC | SELL | -3,545 @ USD 102.9 | USD -364,781 | The ETF sold 3545 shares of MDT on 2026-02-06. The shares were previously bought for an average price of USD 92.9281. The Medtronic PLC shares were sold for 10.7% higher than average price of previous purchases. This sale made a profit of USD 35,350 The average price that the ETF previously sold MDT share for is USD 89.3293 so the ETF has sold 3545 shares on 2026-02-06 at a higher price than the previous selling average. |
| DHR - Danaher Corporation | SELL | -1,735 @ USD 216.61 | USD -375,818 | The ETF sold 1735 shares of DHR on 2026-02-06. The shares were previously bought for an average price of USD 217.512. The Danaher Corporation shares were sold for -0.4% lower than average price of previous purchases. This resulted in an overall loss of USD 1,565 The average price that the ETF previously sold DHR share for is USD 223.287 which is higher than the selling price of USD 216.61 on 2026-02-06. |
| DHR - Danaher Corporation | SELL | -1,735 @ USD 216.61 | USD -375,818 | The ETF sold 1735 shares of DHR on 2026-02-06. The shares were previously bought for an average price of USD 217.512. The Danaher Corporation shares were sold for -0.4% lower than average price of previous purchases. This resulted in an overall loss of USD 1,565 The average price that the ETF previously sold DHR share for is USD 223.287 which is higher than the selling price of USD 216.61 on 2026-02-06. |
| PFE - Pfizer Inc | SELL | -15,720 @ USD 27.22 | USD -427,898 | The ETF sold 15720 shares of PFE on 2026-02-06. The shares were previously bought for an average price of USD 25.4833. The Pfizer Inc shares were sold for 6.8% higher than average price of previous purchases. This sale made a profit of USD 27,301 The average price that the ETF previously sold PFE share for is USD 25.394 so the ETF has sold 15720 shares on 2026-02-06 at a higher price than the previous selling average. |
| ISRG - Intuitive Surgical Inc | SELL | -980 @ USD 488.15 | USD -478,387 | The ETF sold 980 shares of ISRG on 2026-02-06. The shares were previously bought for an average price of USD 528.978. The Intuitive Surgical Inc shares were sold for -7.7% lower than average price of previous purchases. This resulted in an overall loss of USD 40,011 The average price that the ETF previously sold ISRG share for is USD 533.506 which is higher than the selling price of USD 488.15 on 2026-02-06. |
| GILD - Guild Esports Plc | SELL | -3,430 @ USD 152.5 | USD -523,075 | The ETF sold 3430 shares of GILD on 2026-02-06. The shares were previously bought for an average price of USD 112.421. The Guild Esports Plc shares were sold for 35.7% higher than average price of previous purchases. This sale made a profit of USD 137,471 The average price that the ETF previously sold GILD share for is USD 104.485 so the ETF has sold 3430 shares on 2026-02-06 at a higher price than the previous selling average. |
| ABT - Abbott Laboratories | SELL | -4,805 @ USD 110.83 | USD -532,538 | The ETF sold 4805 shares of ABT on 2026-02-06. The shares were previously bought for an average price of USD 127.405. The Abbott Laboratories shares were sold for -13.0% lower than average price of previous purchases. This resulted in an overall loss of USD 79,643 The average price that the ETF previously sold ABT share for is USD 123.059 which is higher than the selling price of USD 110.83 on 2026-02-06. |
| TMO - Time Out Group plc | SELL | -1,035 @ USD 542.83 | USD -561,829 | The ETF sold 1035 shares of TMO on 2026-02-06. The shares were previously bought for an average price of USD 535.971. The Time Out Group plc shares were sold for 1.3% higher than average price of previous purchases. This sale made a profit of USD 7,099 The average price that the ETF previously sold TMO share for is USD 510.513 so the ETF has sold 1035 shares on 2026-02-06 at a higher price than the previous selling average. |
| AMGN - Amgen Inc | SELL | -1,485 @ USD 384.32 | USD -570,715 | The ETF sold 1485 shares of AMGN on 2026-02-06. The shares were previously bought for an average price of USD 308.468. The Amgen Inc shares were sold for 24.6% higher than average price of previous purchases. This sale made a profit of USD 112,640 The average price that the ETF previously sold AMGN share for is USD 300.598 so the ETF has sold 1485 shares on 2026-02-06 at a higher price than the previous selling average. |
| UNH - UnitedHealth Group Incorporated | SELL | -2,500 @ USD 276.65 | USD -691,625 | The ETF sold 2500 shares of UNH on 2026-02-06. The shares were previously bought for an average price of USD 411.911. The UnitedHealth Group Incorporated shares were sold for -32.8% lower than average price of previous purchases. This resulted in an overall loss of USD 338,153 The average price that the ETF previously sold UNH share for is USD 458.285 which is higher than the selling price of USD 276.65 on 2026-02-06. |
| MRK - Marks Electrical Group PLC | SELL | -6,860 @ USD 121.93 | USD -836,440 | The ETF sold 6860 shares of MRK on 2026-02-06. The shares were previously bought for an average price of USD 92.7971. The Marks Electrical Group PLC shares were sold for 31.4% higher than average price of previous purchases. This sale made a profit of USD 199,852 The average price that the ETF previously sold MRK share for is USD 94.5156 so the ETF has sold 6860 shares on 2026-02-06 at a higher price than the previous selling average. |
| MRK - Merck & Company Inc | SELL | -6,860 @ USD 121.93 | USD -836,440 | The ETF sold 6860 shares of MRK on 2026-02-06. The shares were previously bought for an average price of USD 92.7971. The Merck & Company Inc shares were sold for 31.4% higher than average price of previous purchases. This sale made a profit of USD 199,852 The average price that the ETF previously sold MRK share for is USD 94.5156 so the ETF has sold 6860 shares on 2026-02-06 at a higher price than the previous selling average. |
| ABBV - AbbVie Inc | SELL | -4,880 @ USD 223.43 | USD -1,090,338 | The ETF sold 4880 shares of ABBV on 2026-02-06. The shares were previously bought for an average price of USD 208.769. The AbbVie Inc shares were sold for 7.0% higher than average price of previous purchases. This sale made a profit of USD 71,546 The average price that the ETF previously sold ABBV share for is USD 195.193 so the ETF has sold 4880 shares on 2026-02-06 at a higher price than the previous selling average. |
| JNJ - Johnson & Johnson | SELL | -6,650 @ USD 239.99 | USD -1,595,934 | The ETF sold 6650 shares of JNJ on 2026-02-06. The shares were previously bought for an average price of USD 179.236. The Johnson & Johnson shares were sold for 33.9% higher than average price of previous purchases. This sale made a profit of USD 404,014 The average price that the ETF previously sold JNJ share for is USD 165.779 so the ETF has sold 6650 shares on 2026-02-06 at a higher price than the previous selling average. |
| LLY - Eli Lilly and Company | SELL | -2,190 @ USD 1058.18 | USD -2,317,414 | The ETF sold 2190 shares of LLY on 2026-02-06. The shares were previously bought for an average price of USD 888.87. The Eli Lilly and Company shares were sold for 19.0% higher than average price of previous purchases. This sale made a profit of USD 370,789 The average price that the ETF previously sold LLY share for is USD 836.098 so the ETF has sold 2190 shares on 2026-02-06 at a higher price than the previous selling average. |